Quotation NO.: JL26081401siRNAOligos(PEX5 [Human])siRNA oligos of target genex3siRNA Negatvie… and 3 more items

OBIO Tech, Inc. has been awarded a contract by the University of Virginia, a contracting organization in Virginia, effective September 26, 2026. The contract has a cumulative value of $795 and encompasses the procurement of specialized molecular biology reagents and associated shipping services. The primary deliverables consist of small interfering ribonucleic acid (siRNA) oligonucleotides targeting three distinct human genes: PEX5, TCF7L2, and Catalase, along with corresponding negative control and fluorescein amide (FAM)-labeled control specimens.

The procurement includes 225 units each of siRNA oligos for PEX5, TCF7L2, and Catalase targets, in addition to 225 units of negative control siRNA and FAM-labeled negative control siRNA. The contract also incorporates 120 units of shipping and handling services. All line items are priced at $1 per unit. These reagents are intended for delivery to the University of Virginia buyer and support research applications requiring ribonucleic acid interference methodologies.